Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Cycle Length: 48 weeks
How should patients be monitored during B12 injection therapy
hydroxychloroquine, sulfasalazine, and leflunomide as alternatives or combination partners (triple therapy: MTX + HCQ + SSZ) Step 2 Biologic DMARDs (after inadequate csDMARD response) : Add TNF inhibitor (adalimumab, etanercept, infliximab, certolizumab, golimumab) or non-TNF biologic (abatacept, tocilizumab, rituximab for RF+/anti-CCP+ patients) Step 3 JAK Inhibitors : Tofacitinib, baricitinib, or upadacitinib after biologic DMARD failure or as alternative based on patient preferences and risk profile
The rate of weight loss remained consistent throughout the study period
He has extraordinary bedside manner
